Open AccessBrief Report: Incidence of HIV in a Nationwide Cohort Receiving Pre-exposure Prophylaxis for HIV Prevention
Author(s) -
Puja Van Epps,
Brigid Wilson,
William Garner,
Lauren A. Beste,
Marissa Maier,
Michael Ohl
Publication year - 2019
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000002186
Subject(s) - medicine , pre exposure prophylaxis , emtricitabine , discontinuation , incidence (geometry) , cohort , human immunodeficiency virus (hiv) , poisson regression , retrospective cohort study , confidence interval , cohort study , medical prescription , pediatrics , men who have sex with men , antiretroviral therapy , viral load , immunology , population , environmental health , physics , syphilis , optics , pharmacology
Cases of HIV, while infrequent, have been reported during tenofovir disoproxil fumarate/emtricitabine use as pre-exposure prophylaxis (PrEP). We describe the incidence of HIV and patterns of PrEP use within the Veterans Health Administration (VHA).